Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04199871 · ClinicalTrials.gov registry record · NA
Improving Control of Alignment in Intermittent Exotropia
A NA study of Intermittent Exotropia, sponsored by Retina Foundation of the Southwest.
- Active
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT04199871: Active NA study of Intermittent Exotropia, sponsored by Retina Foundation of the Southwest.
NCT04199871 is a NA study of Intermittent Exotropia that is active but no longer recruiting, run by Retina Foundation of the Southwest. The registered enrollment target is 84 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04199871, a NA study of Intermittent Exotropia, is active but no longer recruiting, sponsored by Retina Foundation of the Southwest.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
Aim 1: To determine whether use of dichoptic movies for 4 weeks may be helpful in improving control of alignment in children with intermittent exotropia (IXT), thus allowing IXT to be managed non-surgically Aim 2: To determine pre-IXT surgery use of dichoptic movies for 4 weeks post-operatively may be helpful in maintaining successful control of alignment in children who have surgical correction of IXT
Primary Outcome
Classification system developed by PEDIG to quantify the degree of control of ocular alignment on a 0-5 scale at distance and near; 0 is best control \[no exotropia unless dissociated, recovers in \<1 second (phoria)\] and 5 is worst control (constant exotropia)
Conditions Studied
Interventions
- OTHER dichoptic 3D movies
Study Locations (1)
Texas
- Eileen E Birch - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2021-03-25 |
| Est. Completion | 2025-12 |
| Phase | NA |
What the registry record for NCT04199871 still lists
NCT04199871 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Intermittent Exotropia appearing as the primary indexed condition, and to 1 intervention - of which dichoptic 3D movies is the first listed.
NCT04199871 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04199871 about?
NCT04199871 is a clinical study titled "Improving Control of Alignment in Intermittent Exotropia". Aim 1: To determine whether use of dichoptic movies for 4 weeks may be helpful in improving control of alignment in children with intermittent exotropia (IXT), thus allowing IXT to be managed non-surgically Aim 2: To determine pre-IXT surgery use of dichoptic movies for 4 weeks post-operatively may ...
What is the current status of trial NCT04199871?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2021-03-25. Estimated completion is 2025-12.
What conditions does trial NCT04199871 study?
This clinical trial studies the following conditions: Intermittent Exotropia.
What interventions are being tested in trial NCT04199871?
The interventions under investigation include: dichoptic 3D movies (OTHER).
Who is sponsoring clinical trial NCT04199871?
This trial is sponsored by Retina Foundation of the Southwest, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04199871 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Intermittent Exotropia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04199871's enrollment target sits among peer trials
84 983rd of 2000 higher than 1,011 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI